Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BAX stock hub

Baxter International Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BAXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.3B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
BAX
In the news

Latest news · BAX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.1
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-15
P25 -105.6P50 -46.5P75 -3.1
ROIC6.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BAX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
261
Groups with data
11
Currency
USD
Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0000010456
Company name
Baxter International Inc.
Country
United States
Country code
US
Cusip
071813109
Employees
37,500
Employees Change
-500%
Employees Change Percent
-1.32
Enterprise value
$17B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
In Index
SP500
Industry
Medical Instruments & Supplies
Isin
US0718131099
Last refreshed
2026-05-10
Market cap
$9.3B
Market cap category
Mid-Cap
Price
$17.99
Price currency
USD
Rev Per Employee
301,866.67x
Sector
Healthcare
Sic
3841
Symbol
BAX
Website
https://www.baxter.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
-11.82%
EV Sales Forward
1.48x
EV/EBIT
18.08x
EV/EBITDA
8.88x
EV/FCF
23.46x
EV/Sales
1.5x
FCF yield
7.78%
Forward P/E
9.07x
P/B ratio
1.54x
P/S ratio
0.82x
PE Ratio10 Y
34.53x
PEG ratio
9.02x
PS Forward
0.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
8.29%
EBITDA Margin
16.86%
FCF margin
6.39%
Gross margin
34.65%
Gross Profit
$3.9B
Gross Profit Growth
-7.28%
Gross Profit Growth Q
-9.66%
Gross Profit Growth3 Y
-10.99%
Gross Profit Growth5 Y
-3.64%
Net Income
$-1.1B
Net Income Growth Years
0%
Pretax Margin
-4.49%
Profit Margin
-9.7%
Profit Per Employee
$-29,280
ROA
2.85
Roa5y
2.55
ROCE
5.81
ROE
-15.01
Roe5y
-9.06
ROIC
6.8
Roic5y
5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
-7.32%
Cagr15y
-1.8%
Cagr1y
-40.66%
Cagr20y
1.18%
Cagr3y
-25.19%
Cagr5y
-25.44%
Div CAGR10
-8.29%
Div CAGR3
-44.34%
Div CAGR5
-27.74%
EPS Growth Years
0
FCF Growth
252.68%
FCF Growth3 Y
-4.76%
FCF Growth5 Y
-10.59%
OCF Growth
88.69%
OCF Growth10 Y
-0.7%
OCF Growth3 Y
-5.49%
OCF Growth5 Y
-8.71%
Revenue Growth
5.1x
Revenue Growth Q
2.9x
Revenue Growth Quarters
7x
Revenue Growth Years
3x
Revenue Growth3 Y
-7.84x
Revenue Growth5 Y
-0.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.55
Assets
$19.8B
Cash
$2B
Current Assets
$6.8B
Current Liabilities
$3.7B
Debt
$9.7B
Debt EBITDA
$4.76
Debt Equity
$1.61
Debt FCF
$13.4
Equity
$6B
Interest Coverage
3.27
Liabilities
$13.8B
Long Term Assets
$13B
Long Term Liabilities
$10.1B
Net Cash
$-7.7B
Net Cash By Market Cap
$-82.55
Net Debt EBITDA
$4.02
Net Debt Equity
$1.27
Net Debt FCF
$10.61
Tangible Book Value
$-3.1B
Tangible Book Value Per Share
$-5.95
WACC
4.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.85
Inventory Turnover
3.3
Net Working Capital
$2B
Quick ratio
1.02
Working Capital
$3.2B
Working Capital Turnover
$3.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.54%
Dividend Growth
-75%
Dividend Growth Years
0%
Dividend per share
$0.04
Dividend Years
56
Dividend Yield
0.22%
Ex Div Date
2026-05-29
Last Dividend
$0.01
Payout Frequency
Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
-53.22%
1Y total return
-40.64%
200-day SMA
20.46
3Y total return
-58.14%
50-day SMA
17.56
50-day SMA vs 200-day SMA
50under200
5Y total return
-76.95%
All Time High
95.19
All Time High Change
-81.1%
All Time High Date
2020-04-20
All Time Low
0.18
All Time Low Change
10,133.22%
All Time Low Date
1968-02-14
ATR
0.74
Beta
0.62
Beta1y
1.91
Beta2y
0.96
Ch YTD
-5.86
High
18
High52
32.68
High52 Date
2025-05-12
High52ch
-44.95%
Low
17.29
Low52
15.73
Low52 Date
2026-03-30
Low52ch
14.37%
Ma50ch
2.47%
Premarket Change Percent
0.86
Premarket Price
$17.64
Premarket Volume
1,976
Price vs 200-day SMA
-12.08%
RSI
53.86
RSI Monthly
31.93
RSI Weekly
44.08
Sharpe ratio
-0.98x
Sortino ratio
-1.06
Total Return
-0.32%
Tr YTD
-5.81
Tr15y
-23.88%
Tr1m
8.24%
Tr1w
4.53%
Tr3m
-17.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
9
Analyst Count Top
2
Analyst Price Target Top
$22
Analyst Ratings
Hold
Analyst Ratings Top
Hold
Earnings EPS Estimate
$0.31
Earnings EPS Estimate Growth
-50
Earnings Revenue Estimate
2,612,385,280x
Earnings Revenue Estimate Growth
-0.48x
Operating Income
$938M
Operating Income Growth
-5.06
Operating Income Growth Q
-37.79
Operating Income Growth3 Y
-13.79
Operating Income Growth5 Y
-12.72
Operating margin
8.29
Price target
$21.25
Price Target Change
$18.12
Price Target Change Top
$22.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
513,915,810%
Float Percent
99.51%
Net Borrowing
-666,000,000
Shares Insiders
0.4%
Shares Institutions
100.41%
Shares Out
516,469,008
Shares Qo Q
0.19%
Shares Yo Y
0.54%
Short Float
7.3%
Short Ratio
4.62
Short Shares
7.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

71
MetricValue
Adjusted FCF
$606M
Average Volume
8,221,352.55x
Bv Per Share
11.7
CAPEX
$-528M
Ch10y
-60.08
Ch15y
-68.87
Ch1m
8.24
Ch1w
4.53
Ch1y
-41.44
Ch20y
-52.89
Ch3m
-17.21
Ch3y
-60.93
Ch5y
-79.23
Ch6m
-0.06
Change
2.86%
Change From Open
1.58
Close
17.49
Days Gap
1.26
Depreciation Amortization
971,000,000
Dollar Volume
141,506,731.5
Earnings Date
2026-04-30
Earnings Time
bmo
EBIT
$938M
EBITDA
$1.9B
EPS
$-2.14
F Score
5
FCF
$723M
FCF EV Yield
4.26x
FCF Per Share
$1.4
Financing CF
-1,001,000,000
Fiscal Year End
December
Founded
1,931
Goodwill
4,899,000,000
Income Tax
$473M
Investing CF
-557,000,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-04-30
Last Report Date
2026-03-31
Last Split Date
2001-05-31
Last Split Type
Forward
Last10k Filing Date
2026-02-12
Ma150
19.26
Ma150ch
-6.59%
Ma20
17.79
Ma20ch
1.12%
Net CF
-277,000,000
Next Earnings Date
2026-07-30
Open
17.71
Optionable
Yes
P FCF Ratio
12.85
P OCF Ratio
7.43
Payment Date
2026-07-01
Position In Range
98.59
Post Close
17.99
Postmarket Change Percent
-0.06
Postmarket Price
$17.98
Ppne
3,190,000,000
Pre Close
17.49
Price Date
2026-05-08
Price EBITDA
$4.87
Relative Volume
0.96x
Revenue
11,320,000,000x
SBC By Revenue
1.03x
Share Based Comp
117,000,000
Tax By Revenue
4.18x
Tr20y
26.35%
Tr6m
0.05%
Us State
Illinois
Volume
7,865,855
Z Score
2.41
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BAX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.2%
$0.04 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-27.7%
0 consecutive years of growth
Total shareholder yield
-0.3%
Next ex-dividend date: 2026-05-29
Performance

BAX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-40.6%
S&P 500 1Y: n/a
3Y total return
-58.1%
S&P 500 3Y: n/a
5Y total return
-76.9%
S&P 500 5Y: n/a
10Y total return
-53.2%
S&P 500 10Y: n/a
Ownership

Who owns BAX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+100.4%
Float: +99.5% of shares outstanding
Insider ownership
+0.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+7.3%
4.6 days to cover
Y/Y dilution
+0.5%
Negative means the company is buying back shares.
Technical

BAX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.9
Neutral momentum band
Price vs 200-day MA
-12.1%
50/200-day relationship not available
Beta (5Y)
0.62
Less volatile than the market
Sharpe ratio
-0.98
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BAX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BAX stock rating?

Baxter International Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BAX analysis?

The full report lives at /stocks/BAX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BAX?

The latest report frames BAX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BAX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.